Implementation of personalised risk prediction and prevention of sudden cardiac death after myocardial infarction

Personalised prevention of sudden cardiac death: from analysis of existing data to large trials

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 847999.

PROFID at ESC 2022

This year, PROFID had a marked presence at the European Society of Cardiology 2022 Congress during the session “Latest Science in Arrhythmias”. Project coordinator Dr. Nikolaos Dagres of the Leipzig Heart Institute presented the final results of the PROFID analysis.

Read More »

ESC/ EHRA – engaged to reduce the burden of cardiovascular diseases

The European Association of Cardiology (ESC) is an independent, non-profit organisation and represents more than 95,000 decision-makers and healthcare professionals in the field of cardiology. The ESC acts in the interest of patients by providing cardiologists with the support and tools they need to deliver the best possible care.

Read More »

Interview – THE PROFID CMR RE-ANALYSIS

In phase one of the development of the PROFID risc prediction model we analysed 19 datasets from Europe, Israel and the US, based on a collection of existing highly phenotyped data with the largest number of post-MI patients (~225,000 observations).

Read More »

EHRA 2022 CONGRESS OUTCOMES

PROFID was featured prominently in two separate sessions at the European Heart Rhythm Association congress – EHRA 2022 in Copenhagen (3 April – 5 April 2022).

Read More »

PROFID at EHRA 2022

We are proud to announce that PROFID has been selected for a Late Breaking Science session at the EHRA 2022 congress in Copenhagen. Dr. Nikolaos Dagres will give a presentation on Sunday, April 3rd at 1:55 pm CET in Room 1.

Read More »

Interview University of Manchester

Prof. Peek from the University of Manchester is leading Work Package 1 “Risk Score Development” of PROFID. Together with his team he analysed 19 data sets (from more than 200.000 patients) to develop a new model for predicting the risk of sudden cardiac death after myocardial infarction.

Read More »

Addressing unmet patient needs

Patients can make a valuable contribution and improve societal impact through their engagement in research projects. In implementing its work, PROFID ensures that patients’ perspective is included through the project partner German Heart Foundation.

Read More »

PROFID at ESC 2021

This year, PROFID had a presence at the European Society of Cardiology 2021 Congress during the session ‘Latest Science in Arrhythmias and Device Therapy’.

Read More »

BMJ Open Heart

Ethical issues in two parallel trials of personalised criteria for implantation of implantable cardioverter defibrillators for primary prevention: the PROFID project

Read More »

PROFID at EHRA 2021

The EHRA 2021 congress is the annual scientific meeting of the project partner European Heart Rhythm Association (EHRA). The online congress was held between Friday 23 April and Sunday 25 April 2021.

Read More »

3rd General Assembly Meeting

PROFID hosted its 3rd General Assembly Meeting on the 5th of March 2021. In this 5 hours online meeting, 56 members of the consortium discussed the project progress and the milestones reached in the first 14 month.

Read More »

Paper: The PROFID project

A large European effort towards personalized prediction and prevention of sudden cardiac death after myocardial infarction funded by the European Union

Read More »

Launch of PROFID

PROFID’s was funded by the European Commission over the Horizon 2020 programme under grant agreement no. 847999. The project has started on 1st January 2020.

Read More »

Subscribe to our newsletter